These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14186516)

  • 1. [INH THERAPY IN INH RESISTANCE].
    SERI I
    Tuberk Tudobetegsegek; 1964 Apr; 17():98-103. PubMed ID: 14186516
    [No Abstract]   [Full Text] [Related]  

  • 2. THIACETAZONE PLUS ISONIAZID IN DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS IN HYDERABAD.
    MENON NK
    Tubercle; 1965 Mar; 46():19-28. PubMed ID: 14296505
    [No Abstract]   [Full Text] [Related]  

  • 3. CHEMOTHERAPY OF PULMONARY TUBERCULOSIS IN ADULTS: THE CHOICE OF DRUGS IN RELATION TO DRUG SUSCEPTIBILITY. A STATEMENT OF THE COMMITTEE ON THERAPY.
    TSUKAMURA M
    Am Rev Respir Dis; 1965 Sep; 92():508-12. PubMed ID: 14346379
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE PROBLEM OF PRIMARY RESISTANCE].
    KATONA L; LAKITS E; PALOS F
    Tuberk Tudobetegsegek; 1964 Apr; 17():111-4. PubMed ID: 14186511
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

  • 6. THE PROBLEM AND MANAGEMENT OF DRUG-RESISTANT CASES OF PULMONARY TUBERCULOSIS IN KENYA.
    ANGAWA JO
    East Afr Med J; 1964 Sep; 41():436-40. PubMed ID: 14229818
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON THE TRANSITION OF SENSITIVITY FOR SM, INH AND PAS OF TUBERCLE BACILLI ISOLATED FROM THE PATIENTS TREATED BY TRIPLE COMBINATION CHEMOTHERAPY INCLUDING SM AND INH WITH SPECIAL REFERENCE TO THEIR CLINICAL COURSE].
    OHSATO T; SHIMIZU H
    Kekkaku; 1965 Jan; 40():19-24. PubMed ID: 14288528
    [No Abstract]   [Full Text] [Related]  

  • 8. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 9. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICAL MEDITATIONS ON "BACTERIAL RESISTANCE" IN CHEMO-ANTIBIOTIC THERAPY OF PULMONARY TUBERCULOSIS].
    CAFIERO F
    Minerva Med; 1964 Sep; 55():2795-800. PubMed ID: 14199467
    [No Abstract]   [Full Text] [Related]  

  • 11. [TREATMENT TRIALS IN PULMONARY TUBERCULOSIS COMBINING ISONIAZID, ADMINISTERED 2 TIMES A WEEK, AND A THIOCARBANILIDE IN DAILY FORM].
    GOMEZ FD; CUNARRODEGIMENO G
    Rev Esp Tuberc; 1964 May; 33():209-21. PubMed ID: 14169312
    [No Abstract]   [Full Text] [Related]  

  • 12. [SOME CONSIDERATIONS ON THE RESISTANCE OF KOCH BACILLI TO ANTIBIOTICS AND ON ITS PRACTICAL IMPORTANCE].
    SANTOS JC
    J Med (Oporto); 1964 Jun; 54():326-30. PubMed ID: 14160477
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESISTANCE OF M. TUBERCULOSIS TO STREPTOMYCIN AND PHTHIVAZID AND INCIDENCE OF POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH PULMONARY TUBERCULOSIS].
    BELOGUROVA VP; SUSLOVA AL
    Probl Tuberk; 1964; 42():44-8. PubMed ID: 14321040
    [No Abstract]   [Full Text] [Related]  

  • 14. [D.A.T.C. IN PULMONARY TUBERCULOSIS IN NON-TREATED PATIENTS].
    REY J; JIMENEZHERRERO J
    Sem Med; 1964 Mar; 124():677-86. PubMed ID: 14167976
    [No Abstract]   [Full Text] [Related]  

  • 15. TREATMENT OF ISONIAZID-RESISTANT TUBERCULOSIS.
    FISCHER DA; KASS I; DYE WE; LESTER W
    Antimicrob Agents Chemother (Bethesda); 1964; 10():699-707. PubMed ID: 14288022
    [No Abstract]   [Full Text] [Related]  

  • 16. [ISONIAZID TREATMENT IN CASES OF ISONIAZID RESISTANCE].
    SERI I
    Prax Pneumol; 1964 Aug; 18():542-51. PubMed ID: 14306998
    [No Abstract]   [Full Text] [Related]  

  • 17. DRUG RESISTANCE AND ITS MANAGEMENT IN PULMONARY TUBERCULOSIS.
    CHAVES AD
    Adv Cardiopulm Dis; 1964; 22():117-26. PubMed ID: 14284208
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
    Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD
    Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BACTERIOLOGICAL STUDY OF 20 SPECIMENS OF RESECTION FOR PULMONARY TUBERCULOSIS IN PATIENTS TREATED WITH CHEMIANTIBIOTICS. (WITH ANATOMIC REFERENCES)].
    FREIJEIRO R; OSORIO HS
    Rev Esp Tuberc; 1963 Dec; 32():585-600. PubMed ID: 14125667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.